Krebs Biochemicals & Industries Quarterly Results for Trading Insights
KREBSBIO • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹-27 Cr
QMarch 2025
Krebs Biochemicals & Industries Quarterly Results Key Highlights
- Revenue of ₹44 Cr in March 2025 (+0.0% vs March 2025, -13.7% vs March 2024)
- Net Profit of ₹-27 Cr in March 2025 (+0.0% vs March 2025, -35.0% vs March 2024)
- EBITDA of ₹-14 Cr in March 2025 (+0.0% vs March 2025)
- Operating Margin of -35.0% in March 2025 (+0.0pp vs March 2025)
- Earnings Per Share of ₹-12.49 in March 2025 (+0.0% vs March 2025)
Krebs Biochemicals & Industries Quarterly Results Analysis
| Metric | 2026 | March 2025 | March 2024 | March 2023 | March 2022 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 28 | 44 | 51 | 53 | 61 | -36.4% | - |
| Net Profit (₹ Cr) | -27 | -27 | -20 | -25 | -45 | - | - |
| EBITDA (₹ Cr) | -15 | -14 | -8 | -15 | -33 | - | - |
| EPS (₹) | -12.70 | -12.49 | -9.15 | -11.30 | -20.81 | - | - |
| Operating Margin (%) | -59.0% | -35.0% | -17.0% | -30.0% | -57.0% | - | - |
Krebs Biochemicals & Industries Share Price Trend Around Quarterly Results
Visualize Krebs Biochemicals & Industries's 1-year price movement across quarterly results — ideal for logging trades in Krebs Biochemicals & Industries share price
chart using Tickjournal. All values in ₹.
Related Pages for Krebs Biochemicals & Industries
Additional stock information and data for KREBSBIO
Revenue Trend (₹ Cr)
March 2023
53
March 2024
51
March 2025
44
2026
28
Net Profit Trend (₹ Cr)
March 2023
-25
March 2024
-20
March 2025
-27
2026
-27
Operating Margin Trend (%)
March 2023
-30.0%
March 2024
-17.0%
March 2025
-35.0%
2026
-59.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Krebs Biochemicals & Industries quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹417,052.40 Cr | 1729.9 | 14,875 | 3,125 | +10.8% | - | 21.0% | 133.1 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6616.5 | 2,860 | 689 | +7.1% | - | 24.1% | 254.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 3963.4 | 3,219 | 591 | +11.3% | - | 18.4% | 226.0 |
|
Cipla
Sept 2025 |
₹118,572.82 Cr | 1465.7 | 7,716 | 1,353 | +12.0% | - | 17.5% | 87.6 |
|
Dr Reddys Laborator…
Sept 2025 |
₹100,998.62 Cr | 1210.1 | 9,135 | 1,337 | +1.1% | - | 14.6% | 74.8 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores